The times when a company is dominating headlines (for all the wrong reasons) are the best time to buy.
Take Medibank Private (ASX: MPL), for example, which you may remember, was embroiled in a data breach in October 2022.
On the news, the stock's share price plummeted more than 20%. And while it still hasn't retraced its steps to its prior glory, astute investors who picked up the private health insurance provider on the cheap would have since enjoyed a return of around 22%.
Today, there are two businesses on the ASX that are similarly making headlines: ResMed (ASX: RMD) and Qantas (ASX: QAN). And while one of these businesses is likely to continue to face headwinds going forward, the other could just be the "most outstanding buy idea on the ASX" today.
That's according to Airlie Funds Management's Emma Fisher, who believes if a company's balance sheet is intact, times of "maximum pain" are usually an investor's best indicator that a business is a buy.
In this episode, Livewire's Ally Selby learns where Emma is seeing the most value on the ASX today, why the data proves it pays to be bullish on the stock market over the long term, what separates the good investors from the great ones, as well as a deep dive on why the team is still buying CSL (ASX: CSL) despite downgrading the stock.
Plus, she also shares why she believes the market is focusing far too much on the macro, as well as the stock she would back if the market were to close for the next five years.
Note: This episode was recorded on Wednesday 27 September 2023.
Uranium Special - The fundies‘ view (part 3)
Uranium Special - Where are we going? (part 2)
Uranium Special - How did we get here? (part 1)
The complete guide to LICs
A hated sector that Ben Graham would love
John Sevior’s simple principles for investment success
Value, growth... Why not both? An interview with Alex Waislitz.
How Harley Grosser turned $100k into $800k in 4 years
How to avoid portfolio bombs
Peter Morgan: The best asset I've ever bought
How to lower your risk and maximise returns
The big picture view on Aussie equities
The ‘special’ stocks Emma Fisher is hitching the Airlie wagon to
Grantham: This is a bubble, this is serious
Preview: Exclusive interview with Jeremy Grantham
Making money from unloved and out-of-favour stocks
Winning the vaccine trade - where to next?
Inside Morgan Stanley’s bullish bet on the recovery
An inflection point for Aussie shares
The biggest question facing investors today
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast